Last Updated : Jan 03, 2018 03:27 PM IST | Source: CNBC-TV18

Hold Aurobindo Pharma, may test Rs 870: Sandeep Wagle

Sandeep Wagle of is of the view that one may hold Aurobindo Pharma.

CNBC TV18 @moneycontrolcom

Sandeep Wagle of told CNBC-TV18, "I would recommend a hold Aurobindo Pharma with a stoploss of Rs 610. I would talk of the next 12-15 months, I would talk of Rs 850-870 kind of a target and then we will revise it if required."

He further added, "I have much higher targets over a two to three year time horizon, so a hold as of now. I would want to give a disclosure that I personally hold it in my portfolio as well as my family portfolio."
First Published on Jan 3, 2018 03:07 pm
Follow us on
Available On
PCI DSS Compliant